differentiated antibiotics

Cempra, Inc. Reports Second Quarter 2014 Financial and Operating Results

Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the second quarter and six months ended June 30, 2014.

 

Cempra, Inc. to Report Second Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on July 29, 2014

CHAPEL HILL, N.C., July 22, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP) today announced that it will report second quarter 2014 financial results and provide a business update after the close of U.S. financial markets on July 29, 2014.